#Japan #Osaka #Alfresa #Mydodes #Hippocrates

Alfresa Corporation to Participate in the 66th Japanese Neurology Conference

Alfresa Corporation, headquartered in Chiyoda, Tokyo, is a vital infrastructure provider in the pharmaceutical distribution sector. The company is set to exhibit at the 66th Annual Japanese Neurology Conference, taking place from May 21 to 24, 2025, at the Osaka International Conference Center. During this event, Alfresa will showcase two of its innovative platforms: Mydodes and Hippocrates. Attendees are warmly invited to visit the Alfresa booth located at 5F Foyer, No. K-17.

Exhibition Highlights

The exhibition will present groundbreaking services aimed at enhancing communication between physicians and medical representatives. Alfresa's mission focuses on improving information exchange among healthcare professionals, assisting them in gathering essential information efficiently.

Mydodes

Mydodes is an advanced chat and web conferencing tool that connects physicians with Alfresa representatives and manufacturers' medical representatives (MRs). Available as both a web and mobile application, Mydodes provides seamless communication, allowing doctors to reach out easily to their contacts anytime and anywhere. Additionally, it features a wealth of information including conference details, administrative updates, and other valuable resources to aid physicians in their practice.

Hippocrates

Hippocrates, Japan’s largest SNS for physicians, forms a robust clinical consultation community. This platform encourages about 72,000 registered physicians to collaborate and freely discuss diagnostic and treatment strategies across various specialties. With Hippocrates, doctors can seek peer support anytime and anywhere, ultimately enhancing the quality of patient care.

Event Details

• - Event Name: The 66th Annual Japanese Neurology Conference
• - Dates: May 21 (Wed) – May 24 (Sat), 2025
• - Venue: Osaka International Conference Center, 5-3-51 Nakanoshima, Kitaku, Osaka City, Osaka Prefecture
• - Alfresa Booth: 5F Foyer, No. K-17
• - Organizer: Tokai University’s Internal Medicine Neurology Department
• - Registration: Conference Participation Registration

Alfresa is committed to continuous improvement in the medical field by ensuring stable pharmaceutical supplies and providing innovative solutions to healthcare settings. The company plays a crucial role in supporting community healthcare and enhancing the well-being of individuals.

About Alfresa Corporation

Since its establishment in 2004, Alfresa Corporation has dedicated 20 years to servicing hospitals and pharmacies by providing medical pharmaceutical products. The company not only supplies pharmaceuticals but also medical devices, testing reagents, and nutritional products, sourcing from approximately 1,000 manufacturers domestically and internationally. Furthermore, Alfresa supports the integration of community-based care systems tailored to regional needs, capitalizing on its network of around 170 locations across Japan. Through various informational services and solution tools, the company contributes to improving operational efficiency and quality in healthcare settings.

Company Overview

• - Name: Alfresa Corporation
• - President: Yusuke Fukujin
• - Business Areas: Wholesaling medical pharmaceuticals, medical devices, testing reagents, caregiving supplies, health foods, and OTC medicines
• - Founded: August 1949
• - Capital: 4.0 billion yen
• - Employees: 5,821 (as of March 31, 2025)
• - Headquarters: 7 Mido-cho, Kanda, Chiyoda-ku, Tokyo 101-8512
• - Company URL: Alfresa Corporation

Alfresa continues to be at the forefront of Japan’s healthcare supply chain, driving initiatives that positively impact public health.